Catalyst Wire Dossier Catalyst Wire Dossier

Saroglitazar Magnesium-V

saroglitazar · Zydus Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Saroglitazar Magnesium-V, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes [Phase 3]

See pricing